BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $31,000 | -52.3% | 11,309 | -6.6% | 0.00% | – |
| Q4 2021 | $65,000 | -38.1% | 12,103 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $105,000 | -32.7% | 12,466 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $156,000 | -39.1% | 12,762 | +21.1% | 0.00% | 0.0% |
| Q1 2021 | $256,000 | -24.0% | 10,539 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $337,000 | +3.1% | 10,510 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $327,000 | +3.2% | 10,812 | +43.8% | 0.00% | 0.0% |
| Q2 2020 | $317,000 | +78.1% | 7,517 | +5.2% | 0.00% | +100.0% |
| Q1 2020 | $178,000 | – | 7,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
| Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
| RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
| Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
| Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
| BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
| Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
| Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
| Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
| Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |